Inventor · disambiguated record
Grant Schoenhard
Also filed as: SCHOENHARD GRANT · SCHOENHARD GRANT L
13 granted patents·15 pending applications·520 citations·filing 2001–2018
95Inventor score
Top patents by PatentIndex Score
28 records- 0197US9517271B2Oral drug delivery systemDURECT CORP·Filed 2015·Granted Dec 13, 2016·21 cites·22 claims
- 0297US9233160B2Oral drug delivery systemDURECT CORP·Filed 2014·Granted Jan 12, 2016·27 cites·23 claims
- 0397US8951556B2Oral drug delivery systemDURECT CORP·Filed 2013·Granted Feb 10, 2015·32 cites·24 claims
- 0497US8945614B2Oral drug delivery systemDURECT CORP·Filed 2013·Granted Feb 3, 2015·32 cites·25 claims
- 0597US8420120B2Oral drug delivery systemYUM SU IL·Filed 2012·Granted Apr 16, 2013·52 cites·26 claims
- 0697US8354124B2Oral drug delivery systemDURECT CORP·Filed 2012·Granted Jan 15, 2013·52 cites·31 claims
- 0797US8168217B2Oral drug delivery systemYUM SU IL·Filed 2007·Granted May 1, 2012·55 cites·23 claims
- 0897US8153152B2Oral drug delivery systemYUM SU IL·Filed 2007·Granted Apr 10, 2012·55 cites·27 claims
- 0997US8147870B2Oral drug delivery systemYUM SU IL·Filed 2007·Granted Apr 3, 2012·55 cites·25 claims
- 1097US8133507B2Oral drug delivery systemYUM SU IL·Filed 2003·Granted Mar 13, 2012·99 cites·29 claims
- 1196US8974821B2Oral drug delivery systemDURECT CORP·Filed 2013·Granted Mar 10, 2015·28 cites·25 claims
- 1282US7034036B2Inhibitors of ABC drug transporters at the blood-brain barrierPAIN THERAPEUTICS INC·Filed 2001·Granted Apr 25, 2006·11 cites·10 claims
- 1380US9918982B2Oral drug delivery systemDURECT CORP·Filed 2016·Granted Mar 20, 2018·1 cites·21 claims
- 1470US2014186437A1Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coatsPAIN THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1569US2018289696A1Oral Drug Delivery SystemDURECT CORP·Filed 2018·Application pending·0 cites
- 1668US2014193490A1Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coatsPAIN THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1764US2004224020A1Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coatsFiled 2003·Application pending·0 cites
- 1862US2008026052A1Oral Dosage Forms with Therapeutically Active Agents In Controlled Release Cores and Immediate Release Gelatin Capsule CoatsSCHOENHARD GRANT L·Filed 2007·Application pending·0 cites
- 1960US2011287093A1Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coatsSCHOENHARD GRANT L·Filed 2010·Application pending·0 cites
- 2058US2009203722A1Novel compositions and methods for enhancing potency or reducing adverse side effects of opiold agonistsPAIN THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2155US2003139352A1Inhibitors of ABC drug transporters in cancer cellsFiled 2002·Application pending·0 cites
- 2255US2005038062A1Methods and materials for the treatment of pain comprising opioid antagonistsFiled 2004·Application pending·0 cites
- 2355US2005245557A1Methods and materials useful for the treatment of arthritic conditions, inflammation associated with a chronic condition or chronic painPAIN THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 2455US2004214848A1Inhibitors of ABC drug transporters in microbial cellsFiled 2002·Application pending·0 cites
- 2546US2003130171A1Inhibitors of ABC drug transporters in multidrug resistant microbial cellsFiled 2001·Application pending·0 cites
- 2646US2006009478A1Methods for the treatment of back painFRIEDMANN NADAV·Filed 2005·Application pending·0 cites
- 2746US2003144312A1Inhibitors of ABC drug transporters in multidrug resistant cancer cellsFiled 2001·Application pending·0 cites
- 2841US2004024004A1Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonistsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Grant Schoenhard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →